PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
Forum rules: The material, content provided by this forum is for informational purpose only and is not intended for substitute to medical advice, diagnosis or treatment.General rules are applicable for this forum- Find Here
  • User avatar
#1853
Some agents have proven teratogenic potential. These agents are summarized. Although the effects of such agents are potentially variable and predictable, their use should be very limited or avoided during pregnancy.

Category D agents have proven teratogenic potential but may, under certain circumstances, be indicated. Prior to using any category D agent, providers should perform a careful review of indications, duration of therapy, all potential.effects, and all potential alternatives to the proposed therapy.

In addition,patients should be informed of these considerations, allowing for informed con-
sent to the proposed therapy. Category X medications have proven teratogenic potential and use should be avoided in pregnancy


Proven Human Teratogens


Category D

Cyclophosphamide
Lithium
Paramethadione
Phenytoin
Barbiturates
Benzodiazepines
Systemic retinoids
Tetracycline
Trimethodione
Valproic acid
Warfarin

Category X

Thalidomide
Danazol
Misoprostil
Diethylstilbesterol
Similar Topics
Topics Statistics Last post
0 Replies 
2419 Views
by Freelancer
0 Replies 
1504 Views
by vasanth
0 Replies 
2302 Views
by nandan
0 Replies 
1297 Views
by Drxsaxena12
Pharmacology-II: Thrombolytic Drugs
by Admund    - In: Pharmacology-II
0 Replies 
2956 Views
by Admund

In recent years, the PharmD program has gained sig[…]

In today's dynamic healthcare landscape, pharmacis[…]

Are you aspiring to pursue a Master of Pharmacy (M[…]

PharmD Info - Highlights